Manage episode 242138451 series 2456542
Finally got around to tackling rituximab in SLE. This is a tough topic: lots of people feel passionately one way or another, flawed observational data supports its use, flawed RCTs did not find significant benefit, and patients are left in the lurch. I tried my best and came away more confident than ever that there's no clear answer. I hope you enjoy; please send me feedback on twitter @ebrheum!